Data / Drug companies / Ropinirole hydrochloride
Ropinirole hydrochloride: 9 companies and 38 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Ropinirole hydrochloride is listed in the FDA National Drug Code Directory by 9 companies, with 38 products in commercial distribution. 38 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, film coated, extended release, and the newest product started marketing on August 19, 2022.
The request: Get every company that lists ropinirole hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 9
- Products
- 38
- Generic (ANDA) products
- 38 (100.0%)
- Application numbers
- 3
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list ropinirole hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Solco Healthcare US, LLC | 14 | tablet, film coated | Generic drugs (ANDA) | September 20, 2011 |
| AvKARE | 5 | tablet, film coated, extended release | Generic drugs (ANDA) | September 13, 2013 |
| Bryant Ranch Prepack | 5 | tablet, film coated | Generic drugs (ANDA) | January 29, 2016 |
| AvPAK | 4 | tablet, film coated | Generic drugs (ANDA) | August 19, 2022 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 4 | tablet, film coated | Generic drugs (ANDA) | January 29, 2016 |
| A-S Medication Solutions | 2 | tablet, film coated | Generic drugs (ANDA) | September 20, 2011 |
| American Health Packaging | 2 | tablet, film coated | Generic drugs (ANDA) | June 10, 2021 |
| Northwind Health Company, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | May 28, 2020 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | September 20, 2011 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 33 | 86.8% |
| Tablet, film coated, extended release | 5 | 13.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 38 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Nonergot Dopamine Agonist | 38 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.